Advancing lab access to lyophilized bead technology
25 Feb 2025
Hear from Brian Kirk, VP of Product Development, as he discusses BioDot’s mission and the growing role of microfluidics in the lab. Learn why lyophilized beads are gaining traction in diagnostics and pharma, and how the Sphera™ Discovery is set to bring lyobead production from larger manufacturing into the lab. Kirk also shares his vision for the future impact of lyobead technology on these industries.
This video was filmed at SLAS 2025.
About the company
BioDot Inc.
BioDot aims to become the principle supplier of sub-microliter dispense systems (for the manufacture of micro-array and microfluidic devices) to Molecular Diagnostics, Theranostics and other emerging markets. This is driven by on-going technology development programs delivering Dispensing Innovation products like BioJet Plus. This unique non-contact nanoliter dispenser delivers genuine on the fly deposition of small drop volumes for high throughput production of Biosensors, BioChips and Protein/Cell arrays.
BioDot is already established as world leader in the supply of equipment and technology for the development and manufacture of membrane Rapid Diagnostic Tests and Biosensors.
BioDot enables, inspires, and educates scientists to commercialize their ideas from R&D through to manufactured product.
Related products
Request Quote for All Products
Sphera™
BioDot Inc.Discrete Droplet Dispensing™, ONLY cooler! Unleash the power of discrete droplet dispensing to enable superior performance. Better Yield. Higher Throughput. Expanded Dynamic Range. BioDot’s platform design expertise applied to the Lyobead formation challenge in an established product.
